Kagawa Prefectural College of Health Sciences, 281-1 Mure-cho, Takamatsu 761-0123, Japan.
Neurochem Res. 2011 Dec;36(12):2244-9. doi: 10.1007/s11064-011-0548-5. Epub 2011 Jul 19.
Parkinson's disease (PD) is characterized by progressive degeneration of dopaminergic neurons in the nigrostriatal system and dopamine (DA) depletion in the striatum. The most popular therapeutic medicine for treating PD, 3-(3,4-Dihydroxyphenyl)-L-alanine (L-DOPA), has adverse effects, such as dyskinesia and disease acceleration. As superoxide (·O(2)(-)) and hydroxyl radical (·OH) have been implicated in the pathogenesis of PD, free radical scavenging and antioxidants have attracted attention as agents to prevent disease progression. Rodents injected with 6-hydroxydopamine (6-OHDA) intracerebroventricularly are considered to be a good animal model of PD. Zingerone and eugenol, essential oils extracted from ginger and cloves, are known to have free radical scavenging and antioxidant effects. Therefore, we examined the effects of zingerone and eugenol on the behavioral problems in mouse model and on the DA concentration and antioxidant activities in the striatum after 6-OHDA administration and L-DOPA treatment. Daily oral administration of eugenol/zingerone and injection of L-DOPA intraperitoneally for 4 weeks following a single 6-OHDA injection did not improve abnormal behaviors induced by L-DOPA treatment. 6-OHDA reduced the DA level in the striatum; surprisingly, zingerone and eugenol enhanced the reduction of striatal DA and its metabolites. Zingerone decreased catalase activity, and increased glutathione peroxidase activity and the oxidized L-ascorbate level in the striatum. We previously reported that pre-treatment with zingerone or eugenol prevents 6-OHDA-induced DA depression by preventing lipid peroxidation. However, the present study shows that post-treatment with these substances enhanced the DA decrease. These substances had adverse effects dependent on the time of administration relative to model PD onset. These results suggest that we should be wary of ingesting these spice elements after the onset of PD symptoms.
帕金森病(PD)的特征是黑质纹状体系统中的多巴胺能神经元进行性退化和纹状体中多巴胺(DA)耗竭。治疗 PD 的最常用的治疗药物 3-(3,4-二羟基苯基)-L-丙氨酸(L-DOPA)具有不良反应,如运动障碍和疾病加速。由于超氧化物(·O(2)(-))和羟基自由基(·OH)被认为与 PD 的发病机制有关,因此自由基清除剂和抗氧化剂作为预防疾病进展的药物引起了关注。向脑室内注射 6-羟多巴胺(6-OHDA)的啮齿动物被认为是 PD 的良好动物模型。姜酮和丁香酚,从生姜和丁香中提取的精油,已知具有自由基清除和抗氧化作用。因此,我们研究了姜酮和丁香酚对 6-OHDA 给药和 L-DOPA 治疗后小鼠模型行为问题以及纹状体中 DA 浓度和抗氧化活性的影响。6-OHDA 单次注射后,每天口服给予丁香酚/姜酮和腹腔内注射 L-DOPA,4 周后不能改善 L-DOPA 治疗引起的异常行为。6-OHDA 降低纹状体中的 DA 水平;令人惊讶的是,姜酮和丁香酚增强了纹状体 DA 及其代谢物的减少。姜酮降低了过氧化氢酶的活性,增加了谷胱甘肽过氧化物酶的活性和纹状体中氧化的 L-抗坏血酸水平。我们之前报道过,姜酮或丁香酚的预处理可通过防止脂质过氧化来预防 6-OHDA 诱导的 DA 降低。然而,本研究表明,这些物质的后期治疗增强了 DA 的减少。这些物质具有与 PD 症状发作相关的时间依赖性的不良反应。这些结果表明,我们应该警惕在 PD 症状发作后摄入这些香料元素。